Form: 3

Initial statement of beneficial ownership of securities

February 6, 2023

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Duban Stefan

(Last) (First) (Middle)
C/O RH
15 KOCH ROAD, SUITE K

(Street)
CORTE MADERA CA 94925

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2023
3. Issuer Name and Ticker or Trading Symbol
RH [ RH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 78 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (1) 05/05/2025 Common Stock 100 87.31 D
Stock Option (Right to Buy) (1) 04/20/2026 Common Stock 160 44.52 D
Stock Option (Right to Buy) (1) 06/26/2026 Common Stock 1,900 25.39 D
Stock Option (Right to Buy) (2) 06/22/2028 Common Stock 6,250 151.35 D
Stock Option (Right to Buy) (3) 04/01/2029 Common Stock 2,125 101.25 D
Stock Option (Right to Buy) (4) 04/28/2030 Common Stock 40,000 154.82 D
Explanation of Responses:
1. This option award is fully vested and exercisable.
2. This option award is vested and exercisable with respect to 4,250 of the shares and will vest and become exercisable with respect to an additional 2,000 shares on June 23, 2023, subject to continuous service.
3. This option award is vested and exercisable with respect to 625 of the shares and will vest and become exercisable with respect to an additional 500 shares on April 2, 2023, and an additional 1,000 shares on April 2, 2024, subject to continuous service.
4. This option award is vested and exercisable with respect to 8,000 shares and will vest and become exercisable with respect to an additional 4,000 shares on April 29, 2023, an additional 6,000 on April 29, 2024, an additional 6,000 on April 29, 2025, an additional 8,000 on April 29, 2026, and an additional 8,000 on April 29, 2027, subject to continuous service.
Remarks:
Chief Gallery and Customer Officer
/s/ Edward T. Lee, Attorney-in-Fact 02/06/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.